![]() ![]() Nkosi Sikelel' iAfrika was composed in 1897 by Enoch Sontonga, a Methodist mission school teacher. The words of the first stanza were originally written in Xhosa as a hymn. Seven additional stanzas in Xhoza were later added by the poet, Samuel Mqhayi. A Sesotho version was published by Moses Mphahlele in 1942. Nkosi Sikelel' iAfrika was popularised at concerts held in Johannesburg by Reverend JL Dube's Ohlange Zulu Choir. It became a popular church hymn that was later adopted as an anthem at political meetings. It was sung as an act of defiance during the Apartheid years. A positive weighted alpha indicates the firm has done well over the course of the year, whereas one below 0 indicates that the firm has done poorly.The first stanza is generally sung in Xhosa or Zulu followed by the Sesotho version. For example, looking both at the price and the high and low measurements of 52 weeks will give you a clearer picture of the direction the price is heading. ![]() ![]() The stock is trading -91.91 percent below its 52-week high and 12.36 percent above its 52-week low. MNPR stock is trading at a margin of -22.46%, -36.45% and -73.78% apart from the 20-Day, 50-Day and 200-Day Simple Moving Average prices.Īs of the close of trading, MNPR deals in the Healthcare domain. Despite the fact that the share price decreased -65.74% in the last 6 months and -53.80% was subtracted to its value over the previous 3 months. The firm’s stock price fluctuated -7.76% within the last five trades and -33.78% within the last 30 trades, which was a significant change from the beginning of this year. The stock price fluctuated between $0.2865 and $0.309 throughout the trading session with the volume trading being 54676 shares, which represented a significant variation when compared to the three months average volume of 922.57K shares. The share price of Monopar Therapeutics Inc (NASDAQ:MNPR) raised 4.92% to close Wednesday’s market session at $0.31, higher as compared to yesterday’s close. The latest trade, Performances and Moving Averages give us the following Picture The rating was released on January 28, 2021, according to finviz. ROTH Capital raised the price target for the Monopar Therapeutics Inc (NASDAQ:MNPR) stock to “a Buy”. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |